Class action lawsuit adds legal overhang to AVAV's SCAR woes

What happened

A shareholder class action has been filed against AeroVironment alleging they understated the likelihood of competition for the SCAR program. This lawsuit echoes the DeepValue report's findings that $1.493B of SCAR options are no longer expected and the program is being reset. The company already recorded a $151.3M goodwill impairment and faces a revenue gap as SCDE remains unprofitable. While the lawsuit formalizes investor claims, it does not change the fundamental thesis that AVAV's near-term earnings bridge depends on replacing SCAR revenue. The stock trades at $166.4, above the $145 attractive entry, with limited margin of safety until SCDE profitability and new awards materialize.

Implication

The class action adds litigation risk and potential settlement costs, but does not alter the core investment thesis that AVAV must replace SCAR revenue and turn SCDE profitable. The DeepValue report already flagged these risks with a WAIT rating and attractive entry at $145. Investors should monitor SCAR recompete progress and SCDE adjusted EBITDA trends over the next 6-12 months. The lawsuit may pressure management to accelerate disclosures, but until SCDE awards and profitability improve, the stock lacks a catalyst. Patience is warranted.

Thesis delta

The class action legalizes the SCAR competition risk investors already priced in, increasing the odds of a bear-case outcome (30% scenario at $115) and extending the re-assessment window. No shift in rating; WAIT remains appropriate.